NEVADA
|
000-54014
|
20-5093315
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
343 Allerton Ave.
South San Francisco, California 94090
|
(Address of principal executive offices)
|
Title
of each class
|
Trading
Symbol(s)
|
Name of
each exchange on which registered
|
Common
Stock, par value $0.001 per share
|
VTGN
|
Nasdaq
Capital Market
|
|
For
|
Against
|
Abstained
|
Votes
|
82,555,822
|
8,624,844
|
349,761
|
% of Shares
Voted
|
90.20%
|
9.42%
|
0.38%
|
|
For
|
Against
|
Abstain
|
Votes
|
83,013,669
|
8,056,166
|
460,592
|
Exhibit No.
|
|
Description
|
|
Certificate
of Amendment to the Restated and Amended Articles of Incorporation,
as amended, of VistaGen Therapeutics, Inc., dated March 5,
2021.
|
|
VistaGen
Therapeutics, Inc.
|
|
|
|
|
Date:
March 5, 2021
|
By:
|
/s/ Shawn K. Singh
|
|
|
Shawn
K. Singh
Chief
Executive Officer
|